Published in Oncogene on September 17, 1998
Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev (2001) 6.15
Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2. Proc Natl Acad Sci U S A (2006) 2.41
Beta-catenin--a linchpin in colorectal carcinogenesis? Am J Pathol (2002) 2.18
Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology. Nat Rev Cancer (2013) 2.17
System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation that are unusually selective in their recruitment properties. Chem Biol (2008) 1.97
The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease. EMBO J (2000) 1.66
Raf kinases: function, regulation and role in human cancer. Biochim Biophys Acta (2007) 1.64
Regulation of nuclear translocation of HDAC3 by IkappaBalpha is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor gamma function. J Biol Chem (2005) 1.63
The phosphoinositide 3-OH kinase/AKT2 pathway as a critical target for farnesyltransferase inhibitor-induced apoptosis. Mol Cell Biol (2000) 1.39
Recognition-domain focused chemosensors: versatile and efficient reporters of protein kinase activity. J Am Chem Soc (2008) 1.31
Apoptosis: targets in pancreatic cancer. Mol Cancer (2003) 1.31
MVB-12, a fourth subunit of metazoan ESCRT-I, functions in receptor downregulation. PLoS One (2007) 1.29
The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression. Pharmacol Ther (2006) 1.27
Prediction of pharmacological and xenobiotic responses to drugs based on time course gene expression profiles. PLoS One (2009) 1.26
Identification of novel in vivo Raf-1 phosphorylation sites mediating positive feedback Raf-1 regulation by extracellular signal-regulated kinase. Mol Biol Cell (2006) 1.24
Differential phosphorylation of NG2 proteoglycan by ERK and PKCalpha helps balance cell proliferation and migration. J Cell Biol (2007) 1.22
Regulation of PPARgamma function by TNF-alpha. Biochem Biophys Res Commun (2008) 1.21
Functions and mechanisms of receptor tyrosine kinase Torso signaling: lessons from Drosophila embryonic terminal development. Dev Dyn (2005) 1.21
A quantitative study of the recruitment potential of all intracellular tyrosine residues on EGFR, FGFR1 and IGF1R. Mol Biosyst (2008) 1.19
Chemopreventive potential of beta-Sitosterol in experimental colon cancer model--an in vitro and In vivo study. BMC Complement Altern Med (2010) 1.18
PVF2, a PDGF/VEGF-like growth factor, induces hemocyte proliferation in Drosophila larvae. EMBO Rep (2002) 1.17
Characterization of mouse Rsk4 as an inhibitor of fibroblast growth factor-RAS-extracellular signal-regulated kinase signaling. Mol Cell Biol (2004) 1.08
Network quantification of EGFR signaling unveils potential for targeted combination therapy. Mol Syst Biol (2013) 1.07
Profiling the global tyrosine phosphorylation state by Src homology 2 domain binding. Proc Natl Acad Sci U S A (2001) 1.06
Potential therapeutics specific to c-MET/RON receptor tyrosine kinases for molecular targeting in cancer therapy. Acta Pharmacol Sin (2010) 1.00
NTRK3 is a potential tumor suppressor gene commonly inactivated by epigenetic mechanisms in colorectal cancer. PLoS Genet (2013) 0.96
G4-DNA formation in the HRAS promoter and rational design of decoy oligonucleotides for cancer therapy. PLoS One (2011) 0.95
Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis. J Clin Invest (2010) 0.94
Plexin B1 suppresses c-Met in melanoma: a role for plexin B1 as a tumor-suppressor protein through regulation of c-Met. J Invest Dermatol (2010) 0.92
Identification of Raf-1 S471 as a novel phosphorylation site critical for Raf-1 and B-Raf kinase activities and for MEK binding. Mol Biol Cell (2005) 0.91
Tyrosine kinase inhibitors in preclinical development. Invest New Drugs (1999) 0.91
Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics. Pharmacol Rev (2013) 0.89
Nicotine, IFN-γ and retinoic acid mediated induction of MUC4 in pancreatic cancer requires E2F1 and STAT-1 transcription factors and utilize different signaling cascades. Mol Cancer (2012) 0.89
Semi-supervised prediction of SH2-peptide interactions from imbalanced high-throughput data. PLoS One (2013) 0.89
Oncogenic tyrosine kinases target Dok-1 for ubiquitin-mediated proteasomal degradation to promote cell transformation. Mol Cell Biol (2011) 0.87
N-Phenyl-2-p-tolylthiazole-4-carboxamide derivatives: Synthesis and cytotoxicity evaluation as anticancer agents. Iran J Basic Med Sci (2014) 0.86
Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma. Metab Brain Dis (2013) 0.83
Dissection of the RET/β-catenin interaction in the TPC1 thyroid cancer cell line. Am J Cancer Res (2011) 0.83
Role of palladin phosphorylation by extracellular signal-regulated kinase in cell migration. PLoS One (2011) 0.82
Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics. Invest New Drugs (2013) 0.82
The Met receptor tyrosine kinase prevents zebrafish primary motoneurons from expressing an incorrect neurotransmitter. Neural Dev (2008) 0.82
In vitro antiproliferative effect of trastuzumab (Herceptin(®)) combined with cetuximab (Erbitux(®)) in a model of human non-small cell lung cancer expressing EGFR and HER2. Clin Exp Med (2015) 0.82
Forcing interactions as a genetic screen to identify proteins that exert a defined activity. Genome Res (2005) 0.81
The RON receptor tyrosine kinase in pancreatic cancer pathogenesis and its potential implications for future targeted therapies. Pancreas (2014) 0.80
ADAM10 controls collagen signaling and cell migration on collagen by shedding the ectodomain of discoidin domain receptor 1 (DDR1). Mol Biol Cell (2014) 0.80
HRAS is silenced by two neighboring G-quadruplexes and activated by MAZ, a zinc-finger transcription factor with DNA unfolding property. Nucleic Acids Res (2014) 0.80
Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation. Oncogene (2015) 0.79
T-cell antigen receptor (TCR) transmembrane peptides: A new paradigm for the treatment of autoimmune diseases. Cell Adh Migr (2010) 0.79
Identification of genes differentially expressed as result of adenovirus type 5- and adenovirus type 12-transformation. BMC Genomics (2009) 0.78
Significance of regenerating islet-derived type IV gene expression in gastroenterological cancers. World J Gastroenterol (2012) 0.78
GC-elements controlling HRAS transcription form i-motif structures unfolded by heterogeneous ribonucleoprotein particle A1. Sci Rep (2015) 0.78
Tumoricidal activity of lauryl gallate towards chemically induced skin tumours in mice. Br J Cancer (2003) 0.78
Antiproliferation effect of imatinib mesylate on MCF7, T-47D tumorigenic and MCF 10A nontumorigenic breast cell lines via PDGFR-β, PDGF-BB, c-Kit and SCF genes. Drug Des Devel Ther (2017) 0.78
Simplification of stochastic chemical reaction models with fast and slow dynamics. J Biol Phys (2007) 0.77
Nucleic Acid Targeted Therapy: G4 Oligonucleotides Downregulate HRAS in Bladder Cancer Cells through a Decoy Mechanism. ACS Med Chem Lett (2015) 0.77
Implications of TGFβ on Transcriptome and Cellular Biofunctions of Palatal Mesenchyme. Front Physiol (2012) 0.76
Targeting met mediated epithelial-mesenchymal transition in the treatment of breast cancer. Clin Transl Med (2014) 0.76
Recent developments in receptor tyrosine kinases targeted anticancer therapy. Vet World (2016) 0.76
Second- and further-line therapy with erlotinib in patients with advanced non-small-cell lung cancer in daily clinical practice. Biomed Res Int (2014) 0.75
A Novel Role of Spred2 in the Colonic Epithelial Cell Homeostasis and Inflammation. Sci Rep (2016) 0.75
Analysis of ALK gene in 133 patients with breast cancer revealed polysomy of chromosome 2 and no ALK amplification. Springerplus (2015) 0.75
Sequential protein kinase reactions controlling cell growth and differentiation. Curr Opin Cell Biol (1994) 1.97
Ligand-independent activation of the platelet-derived growth factor beta receptor: requirements for bovine papillomavirus E5-induced mitogenic signaling. Mol Cell Biol (1995) 1.38
Activation of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase by G protein and tyrosine kinase oncoproteins. J Biol Chem (1993) 1.38
Full activation of the platelet-derived growth factor beta-receptor kinase involves multiple events. J Biol Chem (1998) 1.31
Growth factor receptor tyrosine kinases acutely regulate neuronal sodium channels through the src signaling pathway. J Neurosci (1998) 1.09
14-3-3 proteins interact with specific MEK kinases. J Biol Chem (1998) 1.07
Measuring activation of kinases in mitogen-activated protein kinase regulatory network. Methods Enzymol (1994) 1.06
Signal transduction pathways regulated by arsenate and arsenite. Oncogene (1999) 1.06
MEK-1 phosphorylation by MEK kinase, Raf, and mitogen-activated protein kinase: analysis of phosphopeptides and regulation of activity. Mol Biol Cell (1994) 1.04
Genetic and structural analysis of G protein alpha subunit regulatory domains. J Cell Biochem (1991) 0.80
Analysis of mutant platelet-derived growth factor receptors expressed in PC12 cells identifies signals governing sodium channel induction during neuronal differentiation. Mol Cell Biol (1997) 0.78